^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Serine protease inhibitor

    Related drugs:
    20h
    Tranexamic Acid in Pediatric Idiopathic Scoliosis Surgery (clinicaltrials.gov)
    P=N/A, N=90, Not yet recruiting, Poznan University of Medical Sciences
    New trial
    6d
    Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis (clinicaltrials.gov)
    P1, N=60, Recruiting, Vanderbilt University Medical Center | Trial completion date: Feb 2026 --> Apr 2029 | Trial primary completion date: Feb 2026 --> Apr 2029
    Trial completion date • Trial primary completion date
    9d
    TEAPOT Study Multisite (clinicaltrials.gov)
    P1, N=30, Not yet recruiting, The University of Texas Health Science Center at San Antonio
    New P1 trial
    13d
    CamKid: Effect Camostat for Kidney Protection in Chronic Kidney Disease (clinicaltrials.gov)
    P2, N=40, Recruiting, Odense University Hospital | Completed --> Recruiting
    Enrollment open
    15d
    Tranexamic Acid in Adult Spinal Deformity Surgery (clinicaltrials.gov)
    P3, N=100, Recruiting, Hospital for Special Surgery, New York | Trial completion date: Mar 2026 --> Mar 2027 | Trial primary completion date: Mar 2026 --> Mar 2027
    Trial completion date • Trial primary completion date
    19d
    TEAPOT: TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study (clinicaltrials.gov)
    P1, N=12, Recruiting, The University of Texas Health Science Center at San Antonio | Not yet recruiting --> Recruiting
    Enrollment open
    20d
    Comparison of Anticoagulant Efficacy of Different Doses of Nafamostat Mesylate in Continuous Renal Replacement Therapy (CRRT) in the ICU (ChiCTR2600121852)
    P=N/A, N=92, Zhujiang Hospital of Southern Medical University; Zhujiang Hospital of Southern Medical University
    New trial
    |
    nafamostat
    20d
    Effect of Regional Citrate Anticoagulation Combined with Nafamostat Mesylate on Extracorporeal Circuit Lifespan during Continuous Renal Replacement Therapy: A Prospective, Three-Arm, Randomized Controlled Study in Critically ill Acute Kidney Injury Patients with Sepsis (ChiCTR2600121436)
    P=N/A, N=258, West China Hospital of Sichuan University; West China Hospital of Sichuan University
    New trial
    |
    IL6 (Interleukin 6) • CRP (C-reactive protein)
    |
    nafamostat
    21d
    Study on the Effect of Preoperative Intravenous Tranexamic Acid on Shoulder Arthroscopy: A Prospective, Double-Blind, Randomized Controlled Trial (ChiCTR2600119817)
    P4, N=80, West China Hospital of Sichuan University; West China Hospital of Sichuan University
    New P4 trial
    22d
    TRACES: Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery (clinicaltrials.gov)
    P4, N=225, Completed, University Hospital, Lille | Terminated --> Completed
    Trial completion
    24d
    ASCOT: Effect on Post-operative Pain of Tranexamic Acid Injection During Shoulder Surgery (clinicaltrials.gov)
    P3, N=220, Completed, Elsan | Not yet recruiting --> Completed
    Trial completion
    29d
    Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU) (clinicaltrials.gov)
    P2, N=92, Recruiting, Zhujiang Hospital | Not yet recruiting --> Recruiting
    Enrollment open
    |
    nafamostat